OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Burden of pancreatic cancer along with attributable risk factors in China from 1990 to 2019, and projections until 2030
Jiaqi Chen, Hui Chen, Tongchao Zhang, et al.
Pancreatology (2022) Vol. 22, Iss. 5, pp. 608-618
Closed Access | Times Cited: 12
Jiaqi Chen, Hui Chen, Tongchao Zhang, et al.
Pancreatology (2022) Vol. 22, Iss. 5, pp. 608-618
Closed Access | Times Cited: 12
Showing 12 citing articles:
Burden of drug use disorders in the United States from 1990 to 2021 and its projection until 2035: results from the GBD study
Tongchao Zhang, Lin Sun, Xiaolin Yin, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 15
Tongchao Zhang, Lin Sun, Xiaolin Yin, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 15
Epidemiological Trends of Kidney Cancer Along with Attributable Risk Factors in China from 1990 to 2019 and Its Projections Until 2030: An Analysis of the Global Burden of Disease Study 2019
Qianqian Xu, Tingxiao Zhang, Tong Xia, et al.
Clinical Epidemiology (2023) Vol. Volume 15, pp. 421-433
Open Access | Times Cited: 18
Qianqian Xu, Tingxiao Zhang, Tong Xia, et al.
Clinical Epidemiology (2023) Vol. Volume 15, pp. 421-433
Open Access | Times Cited: 18
Burden of Gastrointestinal Tumors in Asian Countries, 1990–2021: An Analysis for the Global Burden of Disease Study 2021
Donglin Jiang, Yangxue Wu, Ling Liu, et al.
Clinical Epidemiology (2024) Vol. Volume 16, pp. 587-601
Open Access | Times Cited: 6
Donglin Jiang, Yangxue Wu, Ling Liu, et al.
Clinical Epidemiology (2024) Vol. Volume 16, pp. 587-601
Open Access | Times Cited: 6
Analysis and prediction of subarachnoid hemorrhage burden in global, China, and Japan
Peng-Fei Ding, Chao Xing, Yongyue Gao, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access
Peng-Fei Ding, Chao Xing, Yongyue Gao, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access
Metabolic reprogramming shapes the immune microenvironment in pancreatic adenocarcinoma: prognostic implications and therapeutic targets
Weihua Song, Yabin Yu, Shuai Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Weihua Song, Yabin Yu, Shuai Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
The trend in pancreatic cancer incidence from 2009 to 2019 and the prediction from 2020 to 2030: An analysis of provincial data in China
Hao Yu, Yong Jiang, Weigang Miao, et al.
Public Health (2025) Vol. 243, pp. 105693-105693
Closed Access
Hao Yu, Yong Jiang, Weigang Miao, et al.
Public Health (2025) Vol. 243, pp. 105693-105693
Closed Access
Cancer trends and risk factors in China over the past 30 years (1990-2019)
Weiwei Wu, Ruochen Zhang, Yiming Jin, et al.
Journal of Cancer (2023) Vol. 14, Iss. 10, pp. 1935-1945
Open Access | Times Cited: 4
Weiwei Wu, Ruochen Zhang, Yiming Jin, et al.
Journal of Cancer (2023) Vol. 14, Iss. 10, pp. 1935-1945
Open Access | Times Cited: 4
The burden of pancreatic cancer and its attributable risk factors in the Middle East and North Africa region, 1990–2019
Seyed Aria Nejadghaderi, Ali‐Asghar Kolahi, Maryam Noori, et al.
Journal of Gastroenterology and Hepatology (2023) Vol. 38, Iss. 9, pp. 1535-1545
Closed Access | Times Cited: 3
Seyed Aria Nejadghaderi, Ali‐Asghar Kolahi, Maryam Noori, et al.
Journal of Gastroenterology and Hepatology (2023) Vol. 38, Iss. 9, pp. 1535-1545
Closed Access | Times Cited: 3
Pancreatic cancer challenge in 52 Asian countries: age-centric insights and the role of modifiable risk factors (1990-2019)
Xin Xiang, Xuejie Chen, Yue He, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Xin Xiang, Xuejie Chen, Yue He, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Feasibility of 125I brachytherapy combined with arterial infusion chemotherapy in patients with advanced pancreatic cancer
Shujing Huang, Yanqing Cao, Rui Wang, et al.
Medicine (2023) Vol. 102, Iss. 44, pp. e35033-e35033
Open Access | Times Cited: 2
Shujing Huang, Yanqing Cao, Rui Wang, et al.
Medicine (2023) Vol. 102, Iss. 44, pp. e35033-e35033
Open Access | Times Cited: 2
Pancreatic Cancer and its Attributable Risk Factors in East Asia, Now and Future
Kuiwu Ren, Chunlong Liu, Ziqiang He, et al.
The Oncologist (2023) Vol. 28, Iss. 11, pp. e995-e1004
Open Access | Times Cited: 1
Kuiwu Ren, Chunlong Liu, Ziqiang He, et al.
The Oncologist (2023) Vol. 28, Iss. 11, pp. e995-e1004
Open Access | Times Cited: 1
A Novel Aging-Related lncRNAs Signature-Based Model for Prognosis Prediction in Pancreatic Cancer
李 Xinxiong, Meiping wang, Zaizhong Zhang, et al.
Research Square (Research Square) (2023)
Open Access
李 Xinxiong, Meiping wang, Zaizhong Zhang, et al.
Research Square (Research Square) (2023)
Open Access
Initial chemotherapy option for pancreatic ductal adenocarcinoma in patients with adequate performance status
Jiazhang Xing, Yuping Ge, Xiaolei Gong, et al.
Journal of Pancreatology (2023) Vol. 6, Iss. 4, pp. 196-201
Open Access
Jiazhang Xing, Yuping Ge, Xiaolei Gong, et al.
Journal of Pancreatology (2023) Vol. 6, Iss. 4, pp. 196-201
Open Access
